IGF1 and cancer: Owing to its anti-inflammatory and antioxidant profile, MD decreases inflammatory markers such as IL-6, TNF-α, and CRP, normalises insulin and IGF-1 concentrations (both of which are involved in cancer formation), and normalises gut microbiota homeostasis by increasing the integrity of the intestinal barrier [89].